362 related articles for article (PubMed ID: 12094371)
1. Clinical management of gastrointestinal stromal tumors: before and after STI-571.
Dematteo RP; Heinrich MC; El-Rifai WM; Demetri G
Hum Pathol; 2002 May; 33(5):466-77. PubMed ID: 12094371
[TBL] [Abstract][Full Text] [Related]
2. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
3. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).
Demetri GD
Eur J Cancer; 2002 Sep; 38 Suppl 5():S52-9. PubMed ID: 12528773
[TBL] [Abstract][Full Text] [Related]
4. The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571).
DeMatteo RP
Ann Surg Oncol; 2002 Nov; 9(9):831-9. PubMed ID: 12417503
[TBL] [Abstract][Full Text] [Related]
5. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
Demetri GD
Semin Oncol; 2001 Oct; 28(5 Suppl 17):19-26. PubMed ID: 11740803
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era.
Wu PC; Langerman A; Ryan CW; Hart J; Swiger S; Posner MC
Surgery; 2003 Oct; 134(4):656-65; discussion 665-6. PubMed ID: 14605627
[TBL] [Abstract][Full Text] [Related]
7. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
8. Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes, and challenges to rational drug development.
Demetri GD
Hematol Oncol Clin North Am; 2002 Oct; 16(5):1115-24. PubMed ID: 12512386
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate.
Koh JS; Trent J; Chen L; El-Naggar A; Hunt K; Pollock R; Zhang W
Histol Histopathol; 2004 Apr; 19(2):565-74. PubMed ID: 15024716
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.
Miettinen M; El-Rifai W; H L Sobin L; Lasota J
Hum Pathol; 2002 May; 33(5):478-83. PubMed ID: 12094372
[TBL] [Abstract][Full Text] [Related]
11. Giant malignant gastrointestinal stromal tumors: recurrence and effects of treatment with STI-571.
Chen TW; Liu HD; Shyu RY; Yu JC; Shih ML; Chang TM; Hsieh CB
World J Gastroenterol; 2005 Jan; 11(2):260-3. PubMed ID: 15633227
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors.
Kitamura Y; Hirota S; Nishida T
Cancer Sci; 2003 Apr; 94(4):315-20. PubMed ID: 12824897
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of gastrointestinal stromal tumors: a consensus approach.
Fletcher CD; Berman JJ; Corless C; Gorstein F; Lasota J; Longley BJ; Miettinen M; O'Leary TJ; Remotti H; Rubin BP; Shmookler B; Sobin LH; Weiss SW
Int J Surg Pathol; 2002 Apr; 10(2):81-9. PubMed ID: 12075401
[TBL] [Abstract][Full Text] [Related]
14. The reappraisal of gastrointestinal stromal tumors: from Stout to the KIT revolution.
Dei Tos AP
Virchows Arch; 2003 May; 442(5):421-8. PubMed ID: 12759750
[TBL] [Abstract][Full Text] [Related]
15. The role of KIT in the management of patients with gastrointestinal stromal tumors.
Hornick JL; Fletcher CD
Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of gastrointestinal stromal tumors: A consensus approach.
Fletcher CD; Berman JJ; Corless C; Gorstein F; Lasota J; Longley BJ; Miettinen M; O'Leary TJ; Remotti H; Rubin BP; Shmookler B; Sobin LH; Weiss SW
Hum Pathol; 2002 May; 33(5):459-65. PubMed ID: 12094370
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumors--a review.
Joensuu H; Kindblom LG
Acta Orthop Scand Suppl; 2004 Apr; 75(311):62-71. PubMed ID: 15188667
[TBL] [Abstract][Full Text] [Related]
18. Management of malignant gastrointestinal stromal tumours.
Joensuu H; Fletcher C; Dimitrijevic S; Silberman S; Roberts P; Demetri G
Lancet Oncol; 2002 Nov; 3(11):655-64. PubMed ID: 12424067
[TBL] [Abstract][Full Text] [Related]
19. Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.
Caram MV; Schuetze SM
J Surg Oncol; 2011 Dec; 104(8):888-95. PubMed ID: 22069173
[TBL] [Abstract][Full Text] [Related]
20. microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome.
Akçakaya P; Caramuta S; Åhlen J; Ghaderi M; Berglund E; Östman A; Bränström R; Larsson C; Lui WO
Br J Cancer; 2014 Nov; 111(11):2091-102. PubMed ID: 25349971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
